 RACORVAL A
|
Roemmers
|
| valsartán+amlodipina |
Antihipertensivo |
| 160/10 mg comp.rec.x 30 | $47.863,00 | (27/04/26) |
| PAMI |
|
| AF $19.989,88 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $27.555,31 AF $20.307,69 |
|
|
|
|
| 160/5 mg comp.rec.x 30 | $46.823,00 | (27/04/26) |
| PAMI |
|
| AF $19.332,08 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $26.450,62 AF $20.372,38 |
|
|
|
|
| 160/10 mg comp.rec.x 60 | $93.712,00 | (25/03/26) |
|
|
|
| 160/5 mg comp.rec.x 60 | $90.034,00 | (25/03/26) |
|
|
|
| 160/5 mg comp.rec.x 28 | $45.534,00 | (27/04/26) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $20.988,55 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $26.023,39 AF $19.510,61 |
|
|
|
|
| 160/10 mg comp.rec.x 28 | $46.874,00 | (27/04/26) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $19.314,74 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $27.433,91 AF $19.440,09 |
|
|
|
|
| |
